Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Cabell Christopher

SEC-identified person · CIK 1814928 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Inhibikase Therapeutics, Inc. IKT President & Head of R&D filed 2025–2026
Zura Bio Ltd ZURA EVP and CMO filed 2023–2023
Ruthigen, Inc. RTGN Director filed 2020–2023
Arena Pharmaceuticals INC ARNA EVP, Head of R&D, and CMO filed 2020–2020

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.